New therapy shows promise for heart failure patients
September 1st, 2009 - 2:14 pm ICT by ANILondon, Sept 1 (ANI) A major international study has found that a therapy called cardiac resynchronization can significantly delay the progression of heart failure.
In the study, researchers found that the treatment reduced the risk of serious heart failure events by 41 percent.
“This shows, for the first time, that the onset of heart failure symptoms and hospitalization for heart failure can be delayed with pacing therapy,” said Dr. David Wilber, a co-author of the study and director of the Cardiovascular Institute at Loyola University Chicago Stritch School of Medicine.
A device implanted in the upper chest delivers electrical impulses that help synchronize contractions of the left ventricle, the heart’s main pumping chamber.
For the study, Wilber and colleagues included 1,820 patients from 110 centers in the United States, Canada and Europe. Loyola enrolled 13 patients. All patients in the trial had been diagnosed with early stage, mild heart failure (Class 1 and Class 2 on the New York Heart Association classification system).
Patients were randomly assigned to two groups. A control group received an implanted defibrillator, and a second group received a defibrillator plus cardiac resychronization. (A defibrillator is a device that shocks the heart back to a normal rhythm if the patient experiences a life-threatening irregular heartbeat.)
The researchers found that compared with the control group, the cardiac resychronization group had a significantly improved heart-pumping efficiency and a 41 percent lower risk of heart-failure events that required hospitalization or outpatient treatment with intravenous drugs.
The Food and Drug Administration has approved cardiac resychronization for patients with Class 3 (moderate) and Class 4 (severe) heart failure. Such patients experience marked limitations in physical activity or are unable to do any physical activity at all without discomfort.
“With this study, we have shown that certain patients with early-stage, mild heart failure also can benefit from cardiac resychronization,” Wilber said.
The study was presented at the European Society of Cardiology Congress in Barcelona.
It has been published in the New England Journal of Medicine. (ANI)
- 'Resynchronisation' cuts down risk of heart failures - Sep 01, 2009
- New therapy to prevent heart failure - Sep 02, 2009
- New implant synchronizes and strengthens fading heart beat: Study - Nov 15, 2010
- Therapy to prevent heart failure more beneficial for women than men - Feb 08, 2011
- New therapy prevents heart failure - Jun 24, 2009
- Women derive double benefit from heart failure device than men - May 14, 2010
- St. Jude to provide latest medical technologies to India - Apr 19, 2012
- One in 25 Indians carries gene that triggers heart failure - Jun 10, 2010
- Top 10 major advances in heart disease in 2010 - Dec 22, 2010
- Diseased heart valve replaced through small hole in the leg - Feb 22, 2011
- Heart surgery can cause strokes, seizures - Nov 17, 2010
- Rest can undo damage to heart cells - Apr 02, 2012
- Device boosts libido of men with heart failure - Jun 02, 2011
- Delhi Metro instals equipment to handle cardiac arrests - Feb 23, 2012
- 1 in 25 people from India carries a gene mutation that causes heart failure - Jun 09, 2010
Tags: cardiac resynchronization, cardiovascular institute, chicago stritch school, electrical impulses, failure events, food and drug administration, heart failure, heart failure patients, heart failure symptoms, intravenous drugs, irregular heartbeat, left ventricle, loyola university chicago, loyola university chicago stritch school of medicine, new york heart association, new york heart association classification, outpatient treatment, stritch school of medicine, university chicago stritch school, upper chest